hZIP1 zinc uptake transporter down regulation and zinc depletion in prostate cancer

Molecular Cancer

Volumn 4, Issue , 2005, Pages

  Franklin, Renty B ^a   Feng, Pei ^a   Milon, Beatrice ^a   Desouki, Mohamed M ^b   Singh, Keshav K ^b   Kajdacsy Balla, André ^c   Bagasra, Omar ^d   Costello, Leslie C ^a  

^a UNIVERSITY OF MARYLAND DENTAL SCHOOL   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d CLAFLIN UNIVERSITY   (United States)

Author keywords

Citrate; Prostate cancer; Zinc; ZIP1 gene expression; ZIP1 zinc transporter

Indexed keywords

MESSENGER RNA; UNCLASSIFIED DRUG; ZINC; ZINC TRANSPORTER; ZIP1 PROTEIN; CATION TRANSPORT PROTEIN; CITRIC ACID; SLC39A1 PROTEIN, HUMAN;

ARTICLE; CANCER CELL; CANCER GROWTH; CANCER LOCALIZATION; CARCINOGENESIS; CELL LEVEL; CONTROLLED STUDY; DOWN REGULATION; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; MALE; MOLECULAR GENETICS; PROSTATE ADENOCARCINOMA; PROSTATE HYPERTROPHY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE SECTION; CANCER STAGING; GENETICS; LYMPH NODE; METABOLISM; PATHOLOGY; PROSTATE TUMOR; TUMOR CELL LINE;

CATION TRANSPORT PROTEINS; CELL LINE, TUMOR; CITRIC ACID; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPH NODES; MALE; NEOPLASM STAGING; PROSTATIC NEOPLASMS; RNA, MESSENGER; ZINC;

EID: 26844565027     PISSN: 14764598     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-4-32     Document Type: Article

References (41)

1. Ostrander EA, Stanford JL: Genetics of prostate cancer: Too many loci; too few genes. Am J Hum Genet 2000, 67:1367-1375.
2. Porkka KP, Visakorpi T: Molecular mechanisms of prostate cancer. European Urol 2004, 45:683-691.
3. Costello LC, Franklin RB: The novel role of zinc in the intermediary metabolism of prostate epithelial cells and its implications in prostate malignancy. Prostate 1998, 38:285-296.
4. Dhar NK, Goel TC, Dube PC, Chowdhury AR, Kar AB: Distribution and concentration of zinc in the subcellular fractions of benign hyperplastic and malignant neoplastic human prostate. Exp Mol Pathol 1973, 19:139-142.
5. Gonic P, Oberleas D, Knechtges T, Prasad AS: Atomic absorption determination of zinc in the prostate. Invest Urol 1969, 6:345-347.
6. Gyorkey F, Min K-W, Huff JA, Gyorkey P: Zinc and magnesium in human prostate gland: Normal, hyperplastic, and neoplastic. Cancer Res 1967, 27:1349-1353.
7. Ogunlewe JO, Osegbe DN: Zinc and cadmium concentrations in indigenous blacks with normal, hypertrophic, and malignant prostate. Cancer 1989, 63:1388-1392.
8. Feustal A, Wennrich R, Steiniger D, Klauss P: Zinc and cadmium concentration in prostatic carcinoma of different histological grading in comparison to normal prostate tissue and adenofibromyomatosis (BPH). Urol Res 1982, 10:301-303.
9. Zaichick VY, Sviridova TV, Zaichick SV: Zinc in the human prostate gland: normal, hyperplastic, cancerous. Int Urol Nephr 1997, 29:565-574.
10. Vartsky D. Shilstein S. Bercovich A. Huszar M. Breskin A. Chechik R. Korotinsky S. Malnick SD. Moriel E: Prostatic zinc and prostate specific antigen: an experimental evaluation of their combined diagnostic value. J Urol. 2003, 170:2258-62.
11. Habib FK, Mason MK, Smith PH, Stitch SR: Cancer of the prostate: Early diagnosis by zinc and hormone analysis. Br J Cancer 1979, 39:700-704.
12. Costello LC, Franklin RB: The intermediary metabolism of the prostate: A key to understanding the pathogenesis and progression of prostate malignancy. Oncology 2000, 59:269-282.
13. Costello LC, Feng P, Milon B, Tan M, Franklin RB: The Role of Zinc in the Pathogenesis and Treatment of Prostate Cancer: Critical Issues to Resolve. Prostate Canc Prostate Dis 2004, 7:111-117.
14. Franklin RB, Milon B, Feng P, Costello LC: Zinc and zinc transporters in normal prostate function and the pathogenesis of prostate cancer. Frontiers in Biosciences 2005, 10: 2230-2239.
15. Costello LC, Liu Y, Zou J, Franklin RB: Evidence for a zinc uptake transporter in human prostate cancer cells which is regulated by prolactin and testosterone. J Biol Chem 1999, 274:17499-17504.
16. Franklin RB, Ma J, Zou JB, Kukoyi B, Feng P, Costello LC: hZIP1 is a major zinc uptake transporter for the accumulation of zinc in prostate cells. J Inorg Biochem 2003, 96:435-442.
17. Gaither AL, Eide DJ: Functional expression of the human hZip2 zinc transporter. J Biol Chem 2000, 275:5560-5564.
18. Rishi I, Baidouri H, Abbasi JA, Kajdacsy-Balla A. Pestaner JP. Skacel M. Tubbs R. Bagasra O: Prostate cancer in African-American men is associated with down-regulation of zinc transporters. App Immunohistochem Mol Morph 2003, 11:253-260.
19. Mostofi FK (Fathollah Keshvar), Sesterhenn I, Davis CJ, Sobin LH: Histological typing of prostate tumours. 2nd edition. Berlin; New York: Springer; 2002:115p.
20. Costello LC, Liu Y, Franklin, RB, Kennedy MC: Zinc inhibition of mitochondrial aconitase and its importance in citrate metabolism of prostate epithelial cells. J Biol Chem 1997, 272:28875-28881.
21. Costello, LC, Franklin RB, Liu Y, Feng P, Franklin RB: Zinc causes a shift toward citrate at equilibrium of the m-aconitase reaction of prostate mitochondria. J Inorganic Biochem 2000, 78:97-108.
22. Costello LC, Franklin RB, Kurhanewicz J: The metabolic diagnosis of prostate by magnetic resonance spectroscopy. In Encyclopedia of Cancer, Volume 3. 2nd edition. Elsevier Science; 2002:167-177.
23. Costello LC, Franklin RB, Narayan P: Citrate in the diagnosis of prostate cancer. Prostate 1999, 38:237-245.
24. Kurhanewicz J, Swanson MG, Nelson SJ, Vigneron DB: Combined magnetic resonance imaging and spectroscopic imaging approach to molecular imaging of prostate cancer. J Magnetic Reson Imag 2002, 16:451-463.
25. Costello LC, Feng P, Franklin RB: Mitochondrial Function, Zinc, and Intermediary Metabolism Relationships in Normal Prostate and Prostate Cancer. Mitochondrion2005, 5: 143-153.
26. Costello LC, Franklin RB. "Why Do Tumor Cells Glycolyze?": From Glycolysis Through Citrate To Lipogenesis. Mol Cell Biochem 2005, in press.
27. Costello LC, Guan Z, Kukoyi B, Feng P, Franklin RB: Terminal oxidation and the effects of zinc in prostate versus liver mitochondria. Mitochond 2004, 4:331-338.
28. Liang JY, Liu YY, Zou J, Franklin, RB, Costello LC, Feng P: Inhibitory effect of zinc on human prostatic carcinoma cell growth. Prostate 1999, 40:200-207.
29. Feng P, Liang JY, Li TL, Guan, ZX, Zou J, Franklin RB, Costello LC: Zinc induces mitochondria apoptogenesis in prostate cells. Mol Urol 2000, 4:31-35.
30. Feng P, Li TL, Guan ZX, Franklin RB, Costello LC: Direct effect of zinc on mitochondrial apoptogenesis in prostate cells. Prostate 2002, 52:311-318.
31. Feng P, Li TL, Guan ZX, Franklin RB, Costello LC: Effect of zinc on prostatic tumorigenicity in nude mice. Ann N Y Acad Sci 2003, 1010:316-320.
32. Li H, Myeroff L, Smiraglia D, Romero MF, Pretlow TP, Kasturi L, Lutterbaugh J, Rerko RM, Casey G, Issa JP, Willis J, Willson JK, Plass C, Markowitz SD, SLC5A8, a sodium transporter, is a tumor suppressor gene silenced by methylation in human colon aberrant crypt foci and cancers. Pro. of the National Acad of Sci (USA) 2003, 100:8412-8417.
33. +-monocarboxylate cotransporter. J Physiol (Lond) 2004, 557: 719-731.
34. Ganapathy V. Gopal E. Miyauchi S. Prasad PD. Biological functions of SLC5A8, a candidate tumour suppressor. Biochemical Society Transactions 2005, 33(Pt 1):237-240.
35. Miyauchi S. Gopal E. Fei YJ. Ganapathy V. Functional identification of SLC5A8, a tumor suppressor down-regulated in colon cancer, as a Na(+)-coupled transporter for short-chain fatty acids. Journal of Biological Chemistry 2004, 279:13293-6.
36. Ueno M. Toyota M. Akino K. Suzuki H. Kusano M. Satoh A. Mita H. Sasaki Y. Nojima M. Yanagihara K. Hinoda Y. Tokino T. Imai K. Aberrant methylation and histone deacetylation associated with silencing of SLC5A8 in gastric cancer. Tumour Biology 2004, 253:134-40.
37. Porra V. Ferraro-Peyret C. Durand C. Selmi-Ruby S. Giroud H. Berger-Dutrieux N. Discussin M. Peix JL. Bournaud C. Orgiazzi J. Borson-Chazot F. Dante R. Rousset B. Silencing of the tumor suppressor gene SLC5A8 is associated with BRAF mutations in classical papillary thyroid carcinomas. Journal of Clinical Endocrinology & Metabolism 2005, 905:3028-35.
38. Beck FW, Prasad AS, Butler CE, Sakr WA, Kucuk O, Sarkar FH: Differential expression of hZnT-4 in human prostate tissues. Prostate 2004, 58:374-381.
39. Hasumi M, Suzuki K, Matsui H, Koike H. Ito K, Yamanaka H: Regulation of metallothionein and zinc transporter expression in human prostate cancer cells and tissues. Cancer Letters 2003, 200:187-95.
40. Desouki MM, Rowan BG: SRC kinase and mitogen-activated protein kinases in the progression from normal to malignant endometrium. Clin Cancer Res 2004, 10:546-55.
41. Kurhanewicz J, Vigneron DB, Hricak, H, Narayan P, Carroll P, Nelson SJ: Three dimensional hydrogen-1 MR spectroscopic imaging of the in situ human prostate with (0.24-0.7-cm3) high spatial resolution. Radiology 1996, 198:795-805.